Daclatasvir plus Asunaprevir Treatment for Real-World HCV Genotype 1-Infected Patients in Japan

Background. All-oral combination of direct-acting antivirals could lead to higher sustained virologic response (SVR) in hepatitis C virus (HCV)-infected patients. In the present study, we examined the efficacy and safety of the dual oral treatment with HCV nonstructural protein (NS) 5A inhibitor dac...

Täydet tiedot

Tallennettuna:
Bibliografiset tiedot
Julkaisussa:Int J Med Sci
Päätekijät: Kanda, Tatsuo, Yasui, Shin, Nakamura, Masato, Suzuki, Eiichiro, Arai, Makoto, Haga, Yuki, Sasaki, Reina, Wu, Shuang, Nakamoto, Shingo, Imazeki, Fumio, Yokosuka, Osamu
Aineistotyyppi: Artigo
Kieli:Inglês
Julkaistu: Ivyspring International Publisher 2016
Aiheet:
Research Paper
Linkit:https://ncbi.nlm.nih.gov/pmc/articles/PMC4893555/
https://ncbi.nlm.nih.gov/pubmed/27279790
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.7150/ijms.15519
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!

Samankaltaisia teoksia